![Copay Assistance & Patient Support | [Brand Name] - News Directory 3](https://blog.needymeds.org/wp-content/uploads/2025/06/ChatGPT-Image-Jun-11-2025-10_48_55-AM-1024x683.png "Copay Assistance & Patient Support | [Brand Name]")
Copay Assistance & Patient Support | [Brand Name]
- Soliris, a crucial medication for individuals with rare and life-threatening conditions, often carries a hefty price tag.NeedyMeds connects patients with resources to make medications like Soliris more affordable,...
- Soliris (eculizumab) treats conditions such as generalized myasthenia Gravis (gMG), Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH), and Neuromyelitis Optica Spectrum Disorder (NMOSD).The drug works by...
- The high cost stems from its complex manufacturing process as a biologic medication.
Facing high Soliris costs? This is a crucial medication for rare conditions, but financial assistance is available. Discover how to navigate the expenses with patient assistance programs adn other resources that can significantly reduce your out-of-pocket costs. Soliris (eculizumab) treats serious conditions, and understanding your options is key.Explore programs like AlexionS OneSource and medicare Extra Help to potentially lower your medication costs. The Patient Access Network (PAN) Foundation also provides aid for Myasthenia Gravis patients. NeedyMeds offers personalized support for patients needing copay assistance to determine eligibility for financial aid. For detailed, up-to-date facts, turn to News Directory 3 for the latest on savings and support. Find out how to make Soliris more affordable. Discover what’s next …
Navigating Soliris Cost: Assistance Options for rare Conditions
Soliris, a crucial medication for individuals with rare and life-threatening conditions, often carries a hefty price tag.NeedyMeds connects patients with resources to make medications like Soliris more affordable, regardless of insurance status.
Soliris (eculizumab) treats conditions such as generalized myasthenia Gravis (gMG), Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH), and Neuromyelitis Optica Spectrum Disorder (NMOSD).The drug works by targeting the complement system, reducing immune system damage.Administered intravenously, Soliris can cost over $500,000 annually, making cost-saving measures essential.
The high cost stems from its complex manufacturing process as a biologic medication. While the original patent expired in 2021, additional patents held by Alexion extend through 2027. Amgen launched a biosimilar, Bkemv, in April 2025, potentially offering a lower-cost alternative. Alexion provides financial support programs through its OneSource platform to assist eligible patients.
For those with commercial insurance or no insurance,Alexion’s OneSource offers financial aid. Applicants need to complete the OneSource Patient Enrollment Form, include insurance and pharmacy card copies, and submit the form via email, fax, or mail. enrollment connects patients with a case manager who can assess eligibility for the Patient Assistance Program.
Medicare part B typically covers Soliris, given its administration via infusion. However, out-of-pocket costs can be ample without supplemental insurance. Medicare Extra Help, or the Low-Income Subsidy program, can lower drug expenses for those with limited income and assets. In 2025, eligibility generally requires an income below $22,590 (or $30,660 for couples).Applications are available through the Social security Administration.
The Patient Access Network (PAN) Foundation offers aid to Myasthenia Gravis patients taking Soliris. Eligible individuals can receive up to $10,100 annually. qualification necessitates treatment for myasthenia gravis, U.S. residency, Medicare coverage, prescription for a drug on PAN’s list, and a household income at or below 500% of the Federal Poverty Level. Funding is awarded on a first-come, first-served basis.
What’s next
Soliris offers a lifeline for those with rare conditions, and financial barriers shouldn’t impede access. Resources exist to reduce or eliminate out-of-pocket expenses, regardless of insurance status. NeedyMeds offers resources and personalized support to help determine program eligibility.